Table 3 Analysis of potential risk factors for major LARS
From: The status of low anterior resection syndrome: data from a single-center in China
Variable | LARS | P value | |
|---|---|---|---|
No (n = 149) | Major (n = 62) | ||
Sex | 0.783 | ||
Male | 98 | 42 | |
Female | 51 | 20 | |
Age (years) | 60.4 ± 10.6 | 63.5 ± 10.2 | 0.053 |
<60 | 69 | 23 | 0.219 |
≥60 | 80 | 39 | |
BMI (kg/m2) | 22.47 ± 2.71 | 22.92 ± 3.37 | 0.318 |
T-stage | 0.041 | ||
T1 − 2 | 47 | 11 | |
T3 − 4 | 102 | 51 | |
N-stage | 0.650 | ||
N0 | 101 | 44 | |
N1 − 2 | 48 | 18 | |
Tumor height | 8.59 ± 3.74 | 7.56 ± 3.11 | 0.058 |
≤5 cm | 39 | 19 | 0.155 |
5-10 cm | 76 | 36 | |
≥10 cm | 34 | 7 | |
Hyperlipemia | 0.458 | ||
Yes | 10 | 6 | |
No | 139 | 139 | |
Diabetes | 0.161 | ||
Yes | 14 | 10 | |
No | 135 | 52 | |
Protective stoma | 0.012 | ||
Yes | 23 | 19 | |
No | 126 | 43 | |
Neoadjuvant therapy | 0.990 | ||
Yes | 53 | 22 | |
No | 96 | 40 | |